Literature DB >> 7495347

Transforming growth factor beta 2 in labial salivary glands in Sjögren's syndrome.

H Koski1, Y T Konttinen, X H Gu, J Hietanen, M Malmström.   

Abstract

OBJECTIVE: To compare the distribution and the amount of transforming growth factor beta (TGF beta) in labial salivary glands (LSG) in patients with Sjögren's syndrome (SS) and healthy controls.
METHODS: LSG from SS patients (n = 10) and healthy controls (n = 6) were labelled with peroxidase-antiperoxidase staining for TGF beta 2, which was quantitated in image analysis using Video Interactive Display System software.
RESULTS: In all LSGs in SS and healthy controls, TGF beta 2 was found in endothelial cells of the capillaries and in the capsular and stromal fibroblasts. In LSGs in SS, TGF beta 2 was also found in some lymphocytes in the inflammatory cell foci and in fibroblasts in fibrotic areas. The TGF beta 2 staining index (microns 2/mm2 tissue) was greater in SS than in control LSGs (3670 (SEM 430) v 2061 (176); p < 0.01), with no difference between the primary and secondary forms of SS (p > 0.05).
CONCLUSION: The localisation and the level of expression of TGF beta 2 indicate its involvement in local tissue fibrosis, and may reflect attempts at immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495347      PMCID: PMC1009991          DOI: 10.1136/ard.54.9.744

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

Review 1.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Computerized image-analysis microspectroscopy of tissue sections.

Authors:  M A Pappolla
Journal:  Arch Pathol Lab Med       Date:  1988-08       Impact factor: 5.534

3.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

Review 4.  Transforming growth factor beta in tissue fibrosis.

Authors:  W A Border; N A Noble
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

5.  Deactivation of macrophages by transforming growth factor-beta.

Authors:  S Tsunawaki; M Sporn; A Ding; C Nathan
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

6.  Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts.

Authors:  J K Wright; T E Cawston; B L Hazleman
Journal:  Biochim Biophys Acta       Date:  1991-09-03

Review 7.  Sjögren's syndrome: historical overview and clinical spectrum of disease.

Authors:  N Talal
Journal:  Rheum Dis Clin North Am       Date:  1992-08       Impact factor: 2.670

Review 8.  Some recent advances in the chemistry and biology of transforming growth factor-beta.

Authors:  M B Sporn; A B Roberts; L M Wakefield; B de Crombrugghe
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

9.  Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system.

Authors:  Y Sato; R Tsuboi; R Lyons; H Moses; D B Rifkin
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

10.  Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development.

Authors:  R W Pelton; B Saxena; M Jones; H L Moses; L I Gold
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

View more
  7 in total

Review 1.  Immunopathogenesis of Sjögren's syndrome.

Authors:  Andrea T Borchers; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

2.  Mast cells, extracellular matrix components, TGFbeta isoforms and TGFbeta receptor expression in labial salivary glands in systemic sclerosis.

Authors:  G I Mason; J Hamburger; J B Matthews
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

3.  Conditional overexpression of TGF-beta1 disrupts mouse salivary gland development and function.

Authors:  Bradford E Hall; Changyu Zheng; William D Swaim; Andrew Cho; Chandrasekharam N Nagineni; Michael A Eckhaus; Kathleen C Flanders; Indu S Ambudkar; Bruce J Baum; Ashok B Kulkarni
Journal:  Lab Invest       Date:  2010-02-08       Impact factor: 5.662

Review 4.  The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands.

Authors:  Margherita Sisto; Sabrina Lisi; Domenico Ribatti
Journal:  Histochem Cell Biol       Date:  2018-05-23       Impact factor: 4.304

5.  Sclerosing Sialadenitis Is Associated With Salivary Gland Hypofunction and a Unique Gene Expression Profile in Sjögren's Syndrome.

Authors:  Hongen Yin; Thomas J F Pranzatelli; Benjamin N French; Nan Zhang; Blake M Warner; John A Chiorini
Journal:  Front Immunol       Date:  2021-07-30       Impact factor: 7.561

6.  Salivary gland expression of transforming growth factor beta isoforms in Sjogren's syndrome and benign lymphoepithelial lesions.

Authors:  G I Mason; J Hamburger; S Bowman; J B Matthews
Journal:  Mol Pathol       Date:  2003-02

7.  Sjögren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFβ signaling.

Authors:  Adrienne E G Williams; Kevin Choi; Annie L Chan; Yun Jong Lee; Westley H Reeves; Michael R Bubb; Carol M Stewart; Seunghee Cha
Journal:  Arthritis Res Ther       Date:  2016-05-03       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.